Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
An update from Irhythm Technologies ( (IRTC) ) is now available.
On January 23, 2025, iRhythm Technologies announced that Mojdeh Poul will not seek re-election to its Board of Directors following her recent appointment as President and CEO of Integra LifeSciences Holdings Corporation. Poul’s decision is not due to any disagreement with iRhythm, and this change is part of her transition to her new leadership role, which may influence iRhythm’s future board dynamics.
More about Irhythm Technologies
iRhythm Technologies, Inc. operates in the healthcare industry, focusing on innovative digital health solutions. The company is known for its cardiac monitoring products and services, primarily targeting the medical community with advanced diagnostic solutions.
YTD Price Performance: 23.71%
Average Trading Volume: 438,307
Technical Sentiment Consensus Rating: Sell
Current Market Cap: $3.46B
See more insights into IRTC stock on TipRanks’ Stock Analysis page.
